Neuronetics, Inc. (STIM) Earnings Call Analysis

NASDAQ · Healthcare · Diagnostics & Research

24/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 4

latest quarter score

Earnings Reports

24
Neuronetics (STIM) Q2 2026: Greenbrook Revenue Surges 17% Driving Margin Expansion and Cash Flow Improvement
August 11, 2026
12
Neuronetics (STIM) Q1 2026: Clinic Revenue Jumps 15% as Buy-and-Bill Drives Growth
May 05, 2026
16
Neuronetics (STIM) Q4 2025: Greenbrook Clinics Drive 28% Pro Forma Revenue Growth, Setting Stage for New Therapies
March 17, 2026
14
Neuronetics (STIM) Q3 2025: Greenbrook Clinics Surge 25%, Offsetting Neurostar Revenue Drag
November 04, 2025
14
Neuronetics (STIM) Q2 2025: Greenbrook Drives 23% Sequential Clinic Revenue Jump, Margin Mix in Focus
August 05, 2025
16
Neuronetics (STIM) Q2 2025: Greenbrook Drives 132% Revenue Surge, Margin Mix Shifts Shape Profit Path
August 05, 2025
21
Neuronetics (STIM) Q1 2025: 84% Revenue Surge Driven by Greenbrook Integration and BMP Expansion
May 06, 2025
Neuronetics (STIM) Q4 2024: 11% Revenue Growth Driven by Greenbrook Acquisition and Better Me Provider Expansion
March 04, 2025

Browse all companies